Related Experiment Videos
[Programmed cell death in the pathogenesis of human diseases].
Tomasz Drewa1, Dorota Olszewska, Alina Woźniak
1Katedra i Zakład Biologii AM w Bydgoszczy.
Summary
Cell death and proliferation are key to disease pathogenesis and homeostasis. Gene therapy targeting programmed cell death shows promise for treating diseases linked to abnormal cell viability or mortality.
Area of Science:
- Cell biology
- Pathogenesis
- Homeostasis
Context:
- Cell death and proliferation are critical in disease development.
- Imbalances in cell viability or mortality contribute to various pathologies.
- Diseases range from cancers and viral infections to neurodegenerative disorders and osteoporosis.
Purpose:
- To explore the role of cell death and proliferation in disease.
- To categorize diseases based on cell viability or mortality.
- To investigate the therapeutic potential of programmed cell death induction.
Summary:
- Cell death and proliferation are fundamental to maintaining biological homeostasis.
- Two main categories of disorders exist: those with increased cell viability (e.g., cancer) and those with increased cell mortality (e.g., AIDS).
- Gene therapy strategies aimed at inducing programmed cell death are under preclinical investigation.
Impact:
- Understanding cell death is crucial for comprehending disease pathogenesis.
- Gene therapy offers a novel approach for treating diseases associated with cell death dysregulation.
- Preclinical findings suggest significant therapeutic implications for numerous conditions.